Mar 25, 2026
1:4
For every 4 shares held, investors received 1. The price per share adjusted from $0.68 to $0.17.
The split itself did not change the total investment value.
XTL Biopharmaceuticals Ltd. (XTLB) trades on the NASDAQ Capital Market in the Biotechnology industry.
XTL Biopharmaceuticals Ltd. company overviewThe latest split shown was on March 25, 2026. It was a 1-for-4 reverse split, so shareholders received 1 share for every 4 they held.
This history records 4 reverse splits between October 4, 2012 and March 25, 2026.
Already premium? Sign in